Kaposi's Sarcoma clinical trials at UCSD
4 in progress, 3 open to eligible people
Pomalidomide Treatment in Patients With Kaposi Sarcoma
open to eligible people ages 18 years and up
This phase II trial studies the effect of pomalidomide in treating patients with Kaposi sarcoma. Pomalidomide is a cancer fighting drug that stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells.
La Jolla, California and other locations
Ixazomib for Kaposi Sarcoma
open to eligible people ages 18 years and up
This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
San Diego, California and other locations
Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
open to eligible people ages 18 years and up
This study is being done to understand how many people with HIV (PWH) present for cancer care across the AIDS Malignancy Consortium in the United States and if there are reasons that some PWH choose to participate, or not in cancer clinical trials. Optional quality of life surveys will be used to learn more about how HIV and cancer and HIV and cancer treatment affect people.
La Jolla, California and other locations
sEphB4-HSA in Treating Patients With Kaposi Sarcoma
Sorry, in progress, not accepting new patients
This phase II trial studies recombinant EphB4-HSA fusion protein (EphB4-HSA) in treating patients with Kaposi sarcoma. Recombinant EphB4-HSA fusion protein may block the growth of blood vessels that provide blood to the cancer, and may also prevent cancer cells from growing.
La Jolla, California and other locations
Our lead scientists for Kaposi's Sarcoma research studies include Erin G. Reid.
Last updated: